|
|
||||||||
Clinical |
Peritoneal Dialysis Program,1 Toronto Western Hospital, from the Division of Nephrology, University of Toronto; Division of Nephrology,2 St. Michael's Hospital, Toronto, Ontario, Canada
Correspondence to: S. Ossareh, Nephrology Department, Hasheminejad Kidney Hospital, Iran University of Medical Science, Vanak Square, Tehran 19697, Iran. e-mail: ossareh_s{at}yahoo.com
Background: Erythropoietin (EPO) deficiency of chronic
renal failure (CRF) may be a functional consequence of decreased glomerular
filtration rate and fractional reabsorption of sodium (FRNa).
Decreased FRNa reduces renal oxygen consumption and increases
tissue oxygen pressure, resulting in less EPO production. We hypothesized
that, in CRF patients, there is a positive relationship between EPO production
and FRNa and that, in such patients receiving EPO, a negative
correlation is expected between FRNa and EPO dose.
Methods: Creatinine clearance, FRNa, serum
iron, transferrin, transferrin saturation, ferritin, and intact parathyroid
hormone (iPTH) levels were measured in 91 peritoneal dialysis patients. The
correlation between EPO dose and FRNa was studied.
Results: Mean EPO dose was 7076 ± 4821
units/week and mean FRNa was 93.40% ± 6.14%. A negative
correlation was found between EPO dose and FRNa (r = 0.28, p
< 0.01), and a positive correlation was found between both ferritin and
iPTH and EPO dose (r = 0.39, p < 0.001 and r = 0.35, p < 0.002
respectively). After adjusting for the effect of creatinine clearance,
ferritin, and iPTH, there was still a significant correlation between EPO dose
and FRNa (p < 0.05).
Conclusion: In CRF patients there is a negative
correlation between FRNa and EPO dose, which supports the
hypothesis that EPO deficiency may be related to the decreased renal
oxygen-consuming work of sodium reabsorption.
KEY WORDS: Erythropoietin deficiency; functional erythropoietin deficiency; fractional excretion of Na; anemia of chronic renal failure.
Received 1 September 2005; accepted 7 April 2006.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |